SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bath & Body Works, Inc. – ‘10-K’ for 2/3/24 – ‘EX-97’

On:  Friday, 3/22/24, at 4:40pm ET   ·   For:  2/3/24   ·   Accession #:  701985-24-10   ·   File #:  1-08344

Previous ‘10-K’:  ‘10-K’ on 3/17/23 for 1/28/23   ·   Latest ‘10-K’:  This Filing   ·   29 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/22/24  Bath & Body Works, Inc.           10-K        2/03/24   98:8.3M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.75M 
 2: EX-10.12    Cash Incentive Compensation Performance Plan        HTML     67K 
 3: EX-10.36    Third Amended and Restated Master Aircraft Time     HTML    107K 
                Share Agreement                                                  
 4: EX-21       Subsidiaries of the Registrant                      HTML     28K 
 5: EX-22       List of Guarantor Subsidiaries                      HTML     27K 
 6: EX-23.1     Consent of Ernst & Young LLP                        HTML     27K 
 7: EX-24       Powers of Attorney                                  HTML     51K 
11: EX-97       Financial Restatement Compensation Recoupment       HTML     47K 
                Policy                                                           
 8: EX-31.1     Section 302 Certification of CEO                    HTML     30K 
 9: EX-31.2     Section 302 Certification of CFO                    HTML     30K 
10: EX-32       Section 906 Certification of CEO and CFO            HTML     27K 
17: R1          Cover                                               HTML     92K 
18: R2          Audit Information                                   HTML     31K 
19: R3          Consolidated Statements of Income                   HTML    118K 
20: R4          Consolidated Statements of Comprehensive Income     HTML     58K 
21: R5          Consolidated Balance Sheets                         HTML    143K 
22: R6          Consolidated Balance Sheets Consolidated Balance    HTML     45K 
                Sheets (Parenthetical)                                           
23: R7          Consolidated Statements of Total Equity (Deficit)   HTML    108K 
24: R8          Consolidated Statements of Total Equity (Deficit)   HTML     28K 
                (Parenthetical)                                                  
25: R9          Consolidated Statements of Cash Flows               HTML    111K 
26: R10         Description of Business and Summary of Significant  HTML     73K 
                Accounting Policies                                              
27: R11         Discontinued Operations                             HTML     60K 
28: R12         Revenue Recognition                                 HTML     42K 
29: R13         Net Income Per Share                                HTML     40K 
30: R14         Inventories                                         HTML     33K 
31: R15         Long-Lived Assets                                   HTML     40K 
32: R16         Leases                                              HTML     83K 
33: R17         Intangible Assets                                   HTML     29K 
34: R18         Accrued Expenses and Other                          HTML     38K 
35: R19         Income Taxes                                        HTML    117K 
36: R20         Long-term Debt and Borrowing Facility               HTML     62K 
37: R21         Fair Value Measurements                             HTML     35K 
38: R22         Commitments and Contingencies                       HTML     30K 
39: R23         Shareholders' Equity (Deficit)                      HTML     78K 
40: R24         Share-based Compensation                            HTML     51K 
41: R25         Pay vs Performance Disclosure                       HTML     39K 
42: R26         Insider Trading Arrangements                        HTML     32K 
43: R27         Description of Business and Summary of Significant  HTML    126K 
                Accounting Policies (Policies)                                   
44: R28         Description of Business and Summary of Significant  HTML     32K 
                Accounting Policies (Tables)                                     
45: R29         Discontinued Operations (Tables)                    HTML     61K 
46: R30         Revenue Recognition (Tables)                        HTML     37K 
47: R31         Net Income Per Share (Tables)                       HTML     39K 
48: R32         Inventories (Tables)                                HTML     34K 
49: R33         Long-Lived Assets (Tables)                          HTML     38K 
50: R34         Leases (Tables)                                     HTML     59K 
51: R35         Accrued Expenses and Other (Tables)                 HTML     38K 
52: R36         Income Taxes (Tables)                               HTML    116K 
53: R37         Long-term Debt and Borrowing Facility (Tables)      HTML     61K 
54: R38         Fair Value Measurements (Tables)                    HTML     33K 
55: R39         Shareholders' Equity (Deficit) (Tables)             HTML     69K 
56: R40         Share-based Compensation (Tables)                   HTML     46K 
57: R41         Description of Business and Summary of Significant  HTML     36K 
                Accounting Policies - Narrative (Details)                        
58: R42         Description of Business and Summary of Significant  HTML     45K 
                Accounting Policies - Depreciable Life Range of                  
                Property Plant and Equipment (Details)                           
59: R43         Discontinued Operations - Schedule of               HTML     30K 
                Consideration and Costs Recognized for Transition                
                Service Agreements (Details)                                     
60: R44         Discontinued Operations - Schedule of               HTML     28K 
                Consideration Received for Domestic Transportation               
                Services Agreement (Details)                                     
61: R45         Discontinued Operations - Schedule of Income        HTML     59K 
                (Loss) from Discontinued Operations (Details)                    
62: R46         Discontinued Operations - Schedule of Cash Flow     HTML     40K 
                Statement (Details)                                              
63: R47         Revenue Recognition - Narrative (Details)           HTML     49K 
64: R48         Revenue Recognition - Disaggregation of Revenue     HTML     41K 
                (Details)                                                        
65: R49         Net Income Per Share - Shares Utilized for the      HTML     42K 
                Calculation of Basic and Diluted Earnings per                    
                Share (Details)                                                  
66: R50         Inventories (Details)                               HTML     33K 
67: R51         Long-Lived Assets - Details of Property and         HTML     44K 
                Equipment, Net (Details)                                         
68: R52         Long-Lived Assets - Narrative (Details)             HTML     36K 
69: R53         Leases - Lease Cost (Details)                       HTML     35K 
70: R54         Leases - Narrative (Details)                        HTML     27K 
71: R55         Leases - Lease Maturities (Details)                 HTML     45K 
72: R56         Leases - Lease Term and Discount Rate (Details)     HTML     30K 
73: R57         Leases - Supplemental Cash Flow Information         HTML     31K 
                (Details)                                                        
74: R58         Intangible Assets - Narrative (Details)             HTML     31K 
75: R59         Accrued Expenses and Other (Details)                HTML     44K 
76: R60         Income Taxes - Narrative (Details)                  HTML     45K 
77: R61         Income Taxes - Provision for Income Taxes           HTML     54K 
                (Details)                                                        
78: R62         Income Taxes - Reconciliation of the Statutory      HTML     46K 
                Federal Income Tax Rate and the Effective Tax Rate               
                (Details)                                                        
79: R63         Income Taxes - Effect of Temporary Differences      HTML     59K 
                that Cause Deferred Income Taxes (Details)                       
80: R64         Income Taxes - Activity Related to its              HTML     41K 
                Unrecognized Tax Benefits (Details)                              
81: R65         Long-term Debt and Borrowing Facility - Schedule    HTML     69K 
                of Long-term Debt Instruments (Details)                          
82: R66         Long-term Debt and Borrowing Facility - Schedule    HTML     43K 
                of Principal Payments on Long-term Debt (Details)                
83: R67         Long-term Debt and Borrowing Facility - Issuance    HTML     75K 
                and Repurchase of Notes - Narrative (Details)                    
84: R68         Long-term Debt and Borrowing Facility -             HTML     49K 
                Repurchases (Details)                                            
85: R69         Long-term Debt and Borrowing Facility - Revolving   HTML     59K 
                Facility and Letters of Credit Narrative (Details)               
86: R70         Fair Value Measurements - Carrying Value and Fair   HTML     34K 
                Value of Long-Term Debt, Disclosure (Details)                    
87: R71         Commitments and Contingencies (Details)             HTML     32K 
88: R72         Shareholders' Equity (Deficit) - Narrative          HTML     96K 
                (Details)                                                        
89: R73         Shareholders' Equity (Deficit) - Schedule of        HTML     45K 
                Repurchase of Common Stock (Details)                             
90: R74         Shareholders' Equity (Deficit) - Dividends Paid     HTML     33K 
                (Details)                                                        
91: R75         Share-based Compensation (Narrative) (Details)      HTML     70K 
92: R76         Share-based Compensation - Share-Based              HTML     41K 
                Compensation Expense (Details)                                   
93: R77         Share-based Compensation - Restricted Stock and     HTML     52K 
                Performance Share Units (Details)                                
95: XML         IDEA XML File -- Filing Summary                      XML    169K 
98: XML         XBRL Instance -- bbwi-20240203_htm                   XML   1.62M 
94: EXCEL       IDEA Workbook of Financial Report Info              XLSX    162K 
13: EX-101.CAL  XBRL Calculations -- bbwi-20240203_cal               XML    211K 
14: EX-101.DEF  XBRL Definitions -- bbwi-20240203_def                XML    449K 
15: EX-101.LAB  XBRL Labels -- bbwi-20240203_lab                     XML   1.66M 
16: EX-101.PRE  XBRL Presentations -- bbwi-20240203_pre              XML   1.01M 
12: EX-101.SCH  XBRL Schema -- bbwi-20240203                         XSD    177K 
96: JSON        XBRL Instance as JSON Data -- MetaLinks              522±   763K 
97: ZIP         XBRL Zipped Folder -- 0000701985-24-000010-xbrl      Zip    494K 


‘EX-97’   —   Financial Restatement Compensation Recoupment Policy


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  
Exhibit 97
BATH & BODY WORKS, INC.
FINANCIAL RESTATEMENT COMPENSATION RECOUPMENT POLICY
    
This Bath & Body Works, Inc. Financial Restatement Compensation Recoupment Policy (“Policy”) has been adopted by the Committee (as defined below) on September 28, 2023. This Policy provides for the recoupment of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting requirements under U.S. federal securities laws in accordance with the terms and conditions set forth herein. This Policy is intended to comply with the requirements of Section 10D of the Exchange Act (as defined below) and Section 303A.14 of the NYSE Listed Company Manual.
1.Definitions. For the purposes of this Policy, the following terms shall have the meanings set forth below.
(a)Board” means the Board of Directors of the Company.
(b)Code” means the U.S. Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.
(c)Committee” means the Human Capital & Compensation Committee of the Board, or any successor thereof.
(d)Company” means Bath & Body Works, Inc.
(e)Covered Compensation” means any Incentive-based Compensation “received” by a Covered Executive during the applicable Recoupment Period; provided that:
(i)     such Covered Compensation was received by such Covered Executive (A) after the Effective Date, (B) after such Covered Executive commenced service as an Executive Officer and (C) while the Company had a class of securities publicly listed on a United States national securities exchange; and
    
(ii)     such Covered Executive served as an Executive Officer at any time during the performance period in respect of such Incentive-based Compensation.
For purposes of this Policy, Incentive-based Compensation is “received” by a Covered Executive during the fiscal period in which the Financial Reporting Measure applicable to such Incentive-based Compensation (or portion thereof) is attained, even if the payment or grant of such Incentive-based Compensation occurs thereafter.
(f)Covered Executive” means any current or former Executive Officer.
(g)Effective Date” means October 2, 2023.
(h)Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended.
(i)Executive Officer” means an “officer” of the Company (within the meaning of Rule 16a-1(f) under the Exchange Act).
(j)Financial Reporting Measure” means any (i) measure that is determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements (and any measures that are derived wholly or in part from any such measure), (ii) stock price measure or (iii) total shareholder return measure. For the avoidance of doubt, a Financial Reporting Measure does not need to be presented within the Company’s financial statements or included in a filing with the U.S. Securities and Exchange Commission.
(k)Financial Restatement” means a restatement of the Company’s financial statements due to the material noncompliance of the Company with any financial reporting requirement under U.S. federal securities laws that is required in order to correct:
    


(i)     an error in previously issued financial statements that is material to the previously issued financial statements; or
(ii)     an error that would result in a material misstatement if (A) the error were corrected in the current period or (B) left uncorrected in the current period.
For purposes of this Policy, a Financial Restatement shall not be deemed to occur in the event of a restatement of the Company’s financial statements due to an out-of-period adjustment or a retrospective (1) application of a change in accounting principles; (2) revision to reportable segment information due to a change in the structure of the Company’s internal organization; (3) reclassification due to a discontinued operation; (4) application of a change in reporting entity, such as from a reorganization of entities under common control; or (5) revision for stock splits, reverse stock splits, stock dividends or other changes in capital structure.
(l)Financial Restatement Preparation Date” means the earlier of (i) the date that the Board (or a committee thereof, or the officer(s) of the Company authorized to take such action if Board action is not required) concludes, or reasonably should have concluded, that the Company is required to prepare a Financial Restatement, and (ii) the date on which a court, regulator or other legally authorized body causes the Company to prepare a Financial Restatement.
(m)Incentive-based Compensation” means any compensation (including, for the avoidance of doubt, any cash or equity or equity-based compensation, whether deferred or current) that is granted, earned and/or vested based wholly or in part upon the achievement of a Financial Reporting Measure. For purposes of this Policy, “Incentive-based Compensation” shall also be deemed to include any amounts which were determined based on (or were otherwise calculated by reference to) Incentive-based Compensation (including, without limitation, any amounts under any long-term disability, life insurance or supplemental retirement plan or any notional account that is based on Incentive-based Compensation, as well as any earnings accrued thereon).
(n) NYSE” means the New York Stock Exchange, or any successor thereof.
(o)Recoupment Period” means the three fiscal years completed immediately preceding the date of any applicable Financial Restatement Preparation Date. Notwithstanding the foregoing, the Recoupment Period additionally includes any transition period (that results from a change in the Company’s fiscal year) within or immediately following those three completed fiscal years, provided that a transition period between the last day of the Company’s previous fiscal year end and the first day of its new fiscal year that compromises a period of nine (9) to twelve (12) months would be deemed a completed fiscal year.
2.Recoupment of Erroneously Awarded Compensation.
(a)In the event of a Financial Restatement, if the amount of any Covered Compensation received by a Covered Executive (the “Awarded Compensation”) exceeds the amount of such Covered Compensation that would have otherwise been received by such Covered Executive if calculated based on the Financial Restatement (the “Adjusted Compensation”), the Company shall reasonably promptly recover from such Covered Executive an amount equal to the excess of the Awarded Compensation over the Adjusted Compensation (such excess amount, the “Erroneously Awarded Compensation”), subject to Section (2)(b) hereof.
(b)If the Financial Reporting Measure applicable to the relevant Covered Compensation is a stock price or total shareholder return measure, where the amount of such Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in the Financial Restatement, then the amount of the Erroneously Awarded Compensation shall be determined based on the Committee’s reasonable estimate of the effect of the Financial Restatement on the Company’s stock price or total shareholder return upon which such Covered Compensation was received.
(c)The amount of Erroneously Awarded Compensation shall be calculated on a pre-tax basis.

2



(d)For the avoidance of doubt, the Company’s obligation to recover Erroneously Awarded Compensation is not dependent on (i) if or when the restated financial statements are filed; or (ii) any fault of the Covered Executive for the accounting errors leading to a restatement.
(e)Notwithstanding anything to the contrary in Sections 2(a) through (d) hereof, the Company shall not be required to recover any Erroneously Awarded Compensation in the event that (x) the conditions set forth in either of clause (i) or (ii) are satisfied and (y) the Committee (or a majority of the independent directors serving on the Board) has made a determination that recovery of the Erroneously Awarded Compensation would be impracticable:
(i)    the direct expense paid to a third party to assist in enforcing the recovery of the Erroneously Awarded Compensation under this Policy would exceed the amount of such Erroneously Awarded Compensation to be recovered; provided that, before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation pursuant to this Section 2(e), the Company shall have first made a reasonable attempt to recover such Erroneously Awarded Compensation, documented such reasonable attempt(s) to make such recovery, and provided that documentation to the NYSE; or
(ii)    recovery of the Erroneously Awarded Compensation would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of Sections 401(a)(13) or 411(a) of the Code.
(f)The Company shall not indemnify any Covered Executive, directly or indirectly, for any losses that such Covered Executive may incur in connection with the recovery of Erroneously Awarded Compensation pursuant to this Policy, including through the payment of insurance premiums or gross-up payments.
(g)The Committee shall determine, in its discretion, the manner and timing in which any Erroneously Awarded Compensation shall be recovered from a Covered Executive in accordance with applicable law, including, without limitation, by (i) requiring reimbursement of Covered Compensation previously paid in cash; (ii) seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer or other disposition of any equity or equity-based awards; (iii) offsetting the Erroneously Awarded Compensation amount from any compensation otherwise owed by the Company or any of its affiliates to the Covered Executive; (iv) cancelling outstanding vested or unvested equity or equity-based awards; and/or (v) taking any other remedial and recovery action permitted by applicable law. For the avoidance of doubt, except as set forth in Section 2(e), in no event may the Company accept an amount that is less than the amount of Erroneously Awarded Compensation; provided that, to the extent necessary to avoid any adverse tax consequences to the Covered Executive pursuant to Section 409A of the Code, any offsets against amounts under any nonqualified deferred compensation plans (as defined under Section 409A of Code) shall be made in compliance with Section 409A of the Code.
3.Administration. This Policy shall be administered by the Committee. All decisions of the Committee shall be final, conclusive and binding upon the Company and the Covered Executives and their beneficiaries, heirs, executors, administrators and any other legal representatives. The Committee shall have full power and authority to (i) administer and interpret this Policy, (ii) correct any defect, supply any omission and reconcile any inconsistency in this Policy and (iii) make any other determination and take any other action that the Committee deems necessary or desirable for the administration of this Policy and to comply with applicable law (including Section 10D of the Exchange Act) and applicable stock market or exchange rules and regulations.
4.Amendment/Termination. Subject to Section 10D of the Exchange Act and Section 303A.14 of the NYSE Listed Company Manual, this Policy may be amended or terminated by the Committee at any time. To the extent that any applicable law, stock market or exchange rules or regulations require recovery of Erroneously Awarded Compensation in circumstances in addition to those specified herein, nothing in this Policy shall be deemed to limit or restrict the right or obligation of the Company to recover Erroneously Awarded Compensation to the fullest extent required by such applicable law, stock market or exchange rules and regulations.

3



5.Interpretation. Notwithstanding anything to the contrary herein, this Policy is intended to comply with the requirements of Section 10D of the Exchange Act and Section 303A.14 of the NYSE Listed Company Manual (and any applicable regulations, administrative interpretations or stock market or exchange rules and regulations adopted in connection therewith). The provisions of this Policy shall be interpreted in a manner that satisfies such requirements, and this Policy shall be operated accordingly. If any provision of this Policy would otherwise frustrate or conflict with this intent, the provision shall be interpreted and deemed amended so as to avoid this conflict.
6.Other Compensation Clawback/Recoupment Rights. Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies, rights or requirements with respect to the clawback or recoupment of any compensation that may be available to the Company pursuant to the terms of any similar policy (including, without limitation, the Company’s Supplemental Compensation Recoupment Policy effective as of September 28, 2023 (as amended from time to time, the “Supplemental Policy”) in any employment agreement, offer letter, equity award agreement or similar agreement and any other legal remedies available to the Company, as well as applicable law, stock market or exchange rules, listing standards or regulations; provided, however, that any amounts recouped or clawed back under any other policy (including, without limitation, the Supplemental Policy) shall count toward any required clawback or recoupment under this Policy and vice versa.
7. Exempt Compensation. Notwithstanding anything to the contrary herein, the Company has no obligation to seek recoupment of amounts paid to a Covered Executive which are granted, vested or earned based solely upon the occurrence or non-occurrence of nonfinancial events. Such exempt compensation includes, without limitation, base salary, time-vesting awards, compensation awarded on the basis of the achievement of metrics that are not Financial Reporting Measures or compensation awarded solely at the discretion of the Committee or the Board, provided, that such amounts are in no way contingent on the achievement of any Financial Reporting Measure.
8.Miscellaneous.
(a)Any applicable plan, program, agreement or arrangement (including any award agreement or other document) setting forth the terms and conditions of any compensation covered by this Policy shall be deemed to include the restrictions imposed herein and incorporate this Policy by reference and, in the event of any inconsistency, the terms of this Policy will govern. For the avoidance of doubt, this Policy applies to all compensation that is received on or after the Effective Date, regardless of the date on which the award agreement or other document setting forth the terms and conditions of the Covered Executive’s compensation became effective.
(b)This Policy shall be binding and enforceable against all Covered Executives and their beneficiaries, heirs, executors, administrators or other legal representatives.
(c)If any provision of this Policy is determined to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted by applicable law and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law.


4


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/22/24
For Period end:2/3/24
10/2/23
9/28/234
 List all Filings 


29 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/01/23  Bath & Body Works, Inc.           10-Q        7/29/23   65:5.9M
 3/17/23  Bath & Body Works, Inc.           10-K        1/28/23  115:10M
11/30/22  Bath & Body Works, Inc.           10-Q       10/29/22   65:5.8M
 9/02/22  Bath & Body Works, Inc.           10-Q        7/30/22   76:7.4M
 5/13/22  Bath & Body Works, Inc.           8-K:5,9     5/09/22   11:306K                                   Davis Polk & … LLP 01/FA
 3/18/22  Bath & Body Works, Inc.           10-K        1/29/22  125:12M
 3/11/22  Bath & Body Works, Inc.           8-K:5,8,9   3/10/22   11:245K                                   Toppan Merrill/FA
 1/28/22  Bath & Body Works, Inc.           8-K:5,9     1/27/22   11:357K                                   Toppan Merrill/FA
 8/03/21  Bath & Body Works, Inc.           8-K:1,2,5,8 8/02/21   20:3.1M                                   Broadridge Fin’l So… Inc
 6/03/21  Bath & Body Works, Inc.           10-Q        5/01/21   74:5.3M
 3/19/21  Bath & Body Works, Inc.           10-K        1/30/21  113:11M
 9/30/20  Bath & Body Works, Inc.           8-K:1,2,8,9 9/30/20   12:1.4M                                   Davis Polk & … LLP 01/FA
 6/18/20  Bath & Body Works, Inc.           8-K:1,2,8,9 6/18/20   13:3M                                     Davis Polk & … LLP 01/FA
 5/20/20  Bath & Body Works, Inc.           8-K:5,9     5/14/20   11:250K                                   Davis Polk & … LLP 01/FA
 4/02/20  Bath & Body Works, Inc.           DEF 14A     5/14/20    1:4.4M                                   Broadridge Fin’l So… Inc
 9/06/19  Bath & Body Works, Inc.           10-Q        8/03/19   85:15M
 6/24/19  Bath & Body Works, Inc.           8-K:1,2,8,9 6/20/19    4:376K                                   Broadridge Fin’l So… Inc
 9/11/18  Bath & Body Works, Inc.           S-4                   11:3.1M                                   Broadridge Fin’l So… Inc
 1/23/18  Bath & Body Works, Inc.           8-K:1,8,9   1/23/18    4:415K                                   Donnelley … Solutions/FA
 6/16/16  Bath & Body Works, Inc.           8-K:1,8,9   6/13/16    5:793K                                   Donnelley … Solutions/FA
11/03/15  Bath & Body Works, Inc.           8-K:1,2,8,910/30/15    5:3M
 9/04/15  Bath & Body Works, Inc.           S-8         9/04/15    6:1.8M
 9/04/15  Bath & Body Works, Inc.           10-Q        8/01/15   76:13M
10/29/13  Bath & Body Works, Inc.           S-3ASR     10/29/13    9:1.2M                                   Davis Polk & … LLP 01/FA
 3/23/12  Bath & Body Works, Inc.           10-K        1/28/12  121:25M
10/01/07  Bath & Body Works, Inc.           S-3ASR     10/01/07   12:1.3M                                   Donnelley … Solutions/FA
 6/06/05  Bath & Body Works, Inc.           S-3                    9:304K                                   Davis Polk & … LLP 01/FA
 5/22/03  Bath & Body Works, Inc.           S-3                    9:456K                                   Davis Polk & … LLP 01/FA
 4/18/03  Bath & Body Works, Inc.           S-4                   12:725K                                   Davis Polk & … LLP 01/FA
Top
Filing Submission 0000701985-24-000010   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 4:04:24.2am ET